A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

NCT05096143 · clinicaltrials.gov ↗

COMPLETED

Status

42269

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Sacubitril/valsartan
DRUG: ACEi/ARB

Sponsor

Novartis Pharmaceuticals